NCT05869214

Brief Summary

The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 11, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2023

Completed
Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

May 11, 2023

Last Update Submit

May 11, 2023

Conditions

Heart FailureAtrial FibrillationValvular Heart DiseaseIschemic Heart Disease

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular diseases care management in women will be compared to men in MEA countries according to current practice guidelines

    2 months

Secondary Outcomes (1)

  • Identify inequalities between both genders in terms of: • Healthcare insurance • Incomes • Access to healthcare

    2 months

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients having their consultation in the study participating site.

You may qualify if:

  • All incomers in Cardiovascular (CV) diseases in hospital or out hospital facilities with one of the 4 diagnosis (Heart Failure (HF), Atrial fibrillation (AF), Valvular Heart disease (VHD), ischemic heart disease (IHD)
  • Age over 18 years old
  • Men and Women
  • Signature of consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hedi chaker Hospital

Sfax, Tunisia

RECRUITING

MeSH Terms

Conditions

Heart FailureAtrial FibrillationHeart Valve DiseasesMyocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and SymptomsVascular Diseases

Central Study Contacts

Salem Abdessalem, Dr

CONTACT

salem.abdesselem@gmail.com

Selma Charfeddine, Dr

CONTACT

selma_charfeddine@yahoo.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2023

First Posted

May 22, 2023

Study Start

May 10, 2023

Primary Completion

July 10, 2023

Study Completion

July 10, 2023

Last Updated

May 22, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)